Build status - In Progress
Search filters

Filters
Clear All

Phase

  • 2
  • 5
  • 4
  • 1
  • 4
  • 7
  • 23
  • 15
  • 23

Found 23 Acute Myeloid Leukemia trials

A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

99 years or below
All genders
Phase 1
The purposes of this study are to see if the study drugs, venetoclax and gilteritinib can be safely and effectively combined for the treatment of patients with acute myeloid leukemia (AML) that has returned after prior treatment, or has failed to respond to prior treatment and identify potential biomarkers.
 Study Evaluating Safety and Efficacy of UCART123 in Patients With Relapsed/ Refractory Acute Myeloid Leukemia (AMELI-01)
18 years - 65 years
All genders
Phase 1
Interventional
This study is evaluating the safety and efficacy of UCART targeting CD123 in patients with relapsed/refractory acute myeloid leukemia (AML). The purpose of this study is to evaluate the safety and clinical activity of UCART123v1.2 and determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D).
99 years or below
All genders
Phase 1
Amphivena Therapeutics, Inc. (Amphivena) is studying an investigational drug called AMV564, which may help to treat acute myeloid leukemia (AML). The purpose of this clinical research study is to find the highest tolerable dose that can be given to patients with AML, and to recommend a dose to be used …
99 years or below
All genders
This study investigates a treatment for adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The purpose of this study is to evaluate the effects of an investigational treatment on these conditions.Who can participate: Adults aged 18 and older diagnosed with acute myeloid leukemia or multiple myeloma may be eligible. …
99 years or below
All genders
This study investigates the effects of an investigational treatment in adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The study aims to assess the safety and potential benefits of the investigational treatment for individuals living with these conditions.Who can participate: Adults aged 18 and older with acute myeloid leukemia …
99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
99 years or below
All genders
This study investigates the use of CART-38 in adults with acute myeloid leukemia (AML) and multiple myeloma (MM).The aim is to evaluate the effects of CART-38 on these conditions. Researchers are looking at how well this treatment works and its safety for patients.Who can participate: Participants must be adults aged …
99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
11 - 20 of 23